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PATHOGENESIS OF CYTOMEGALOVIRUS INFECTION
1 . Activation of Virus from Bone Marrow-Derived Lymphocytes
by In Vitro Allogenic Reaction*
BY LARS B . OLDING, FRED C . JENSEN, AND MICHAEL B . A. OLDSTONE
(From the Department of Immunopathology, Scripps Clinic and Research Foundation,
La Jolla, California 92037)
One of the most challenging problems in medicine concerns latent virus infections, in
particular the specific identification of tissues that harbor these viruses, the ways viruses
persist, and the mechanism(s) by which such agents are activated . Cytomegalovirus
(CMV),' like other herpes viruses, can persist within an organism in a latent form despite
the presence of a vigorous antiviral immune response (reviewed in references 1 and 2) .
Several epidemiologic surveys show that 40-80% of humans over the age of 40 have
serologic evidence of prior CMV infection (1-3) and less than 1% of seropositive healthy
individuals shed virus into their urine (4) . CMV infection would be regarded as an
ordinary acute infection associated with numerous subclinical attacks, complete recovery,
and eradication of the virus except that reappearance of this virus is common . For
example, pregnancy is often associated with active CMV infection (5), and this virus has
been recovered from up to 28% of pregnant women (6, 7) . Acute CMV infection occurs in
nearly 90% of patients 1-2 mo after surgery for kidney transplantation (8) . CMV has been
implicated as the cause of a mononucleosis-like illness occurring in patients after open
heart surgery, and available evidence suggests that this infection is apparently transmit-
ted by blood transfusions (9-13) . Both terminal leukemia and Hodgkin's disease in
patients undergoing immunotherapymay also be associated with CMV infection (14) . The
frequent occurrence ofCMV infection in patients undergoing pregnancy, renal transplan-
tation, and blood transfusions suggests that this virus may be activated by means of
immunologic reaction to foreign antigens .
Host-specific CMVs have been demonstrated in several species including guinea
pig, rat, hamster, mouse, and man . The primary CMV infection in mice
(MCMV) is very similar to that in man (15-16) . Using the murine model, we
studied whether MCMV was carried in lymphocytes taken from adult mice
* This is publication no . 898 from Experimental Pathology, Scripps Clinic and Research
Foundation, La Jolla, California 92037. This research was supported by a grant from The National
Foundation-March of Dimes, no . I-364, and in part byU . S. Public Health Service grant AI-07007 and
Expressen's Prenatal Research Fund (Stockholm, Sweden) .
'Abbreviations used in this paper: Con A, concanavalin A ; CMV, cytomegalovirus ; CPE,
cytopathic effects ; FCS, fetal calf serum ; FFU, focus-forming units ; FITC, fluorescein isothiocya-
nate ; LPS, lipopolysaccharide ; MCMV, mouse CMV; MEC, mouse embryo cells ; MuLV, murine
leukemia virus; PBS, phosphate-buffered saline ; PHA-P, phytohemagglutinin-P; PWM, pokeweed
mitogen .
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infected with MCMV in utero or at birth and whether virus could be activated in
vitro by co-cultivation with antigenically foreign tissues.
Animals
Materials and Methods
Pregnant 2- to 3-mo old C3H/HeJ and SWR/J mice were obtained from Jackson Laboratories, Bar
Harbor, Maine, and pregnant 2- to 3-mo old C3H/St, BALB/c, and Ha/ICR mice from the L. C.
Strong Research Foundation, San Diego, Calif. Nude mice were originally obtained from Jacques
Miller, Walter andEliza Hall Research Institute, Melbourne, Australia. These mice have been inbred
in our institute since 1971. The major H-2 alleles of the mice are: C3H/HeJ and C3H/St mice, H-2 1 ;
BALB/c mice, H-2°°; SWR/J mice, H-214; nude mice off BALB/c, H-2°°; nude mice off CBA, H-2'" .
The Ha/ICR mice are outbred.
Pregnant mice were inoculated intraperitoneally (i.p.) 3-5 days before delivery with a 1,000 tissue
culture infective dose (TCIDsa) of MCMV and nursed their own babies. Newborns were inoculated
i.p. with 100 TCID. of the virus within 24 h of birth; C3H/St and Ha/ICR mice were nursed by their
own mothers, C3H/HeJ and nude mice by Ha/ICR foster mothers. C3H/HeJ and C3H/St mice were
sacrified at 2-3 mo, HaACR mice at 5 mo, and nude mice at 2-4 wk of age.
Virus
MCMV was originally provided by Dr. Richard I. Carp, Department of Microbiology, New York
State Institute for Research in Mental Retardation, Staten Island, N. Y., and a virus stock was
maintained in ourlaboratory by passages on BALB/c or Ha/ICR mouse embryo cells (MEC), grown in
minimal essential medium (MEM) with 10% fetal calf serum (FCS), glutamine, and antibiotics
(growth media) . Infected MECwere disrupted by sonication and mixed with the infected supernate.
This pool was fortified with 10% sorbitol and frozen at -70°Cin aliquots . Stock virus when diluted to
10-'/0.2 ml inoculum caused cytopathology in confluent monolayers of BALB/c MEC.
Antibodies to MCMV
The presence of antibodies to MCMV was determined by an immunofluorescence technique with
infected cells as atarget and serum collected from axillary artery blood or plasma obtained from the
orbital venous plexus. Monolayer cultures of BALB/c MEC were grown on cover slips and infected
with MCMV. When such cultures showed cytopathic effects (CPE), the cover slips were washed in
phosphate-buffered saline (PBS) and fixed in absolute ether plus 95% ethanol (1:1) for 10 minand in
95% ethanol for 20 min. Thefixed cells were washed in PBS, incubated initially for 30 minwith sera or
plasma from the infected animals, washed in PBS, and then stained with rabbit antibody to mouse
immunoglobulin G (IgG) conjugated to fluorescein isothiocyanate (FITC) . Techniques for staining,
raising specific antisera, conjugating to FITC, and testing immunologic specificities of the reagents
have been published (17, 18) . Only cultured cells infected with MCMV showed characteristic staining
of intranuclear viral inclusions. An identical pattern was seen in cells infected with MCMV and
stained with amonospecific rabbit antibody to MCMV conjugated with FITC, kindly provided by Dr.
Berge Hampar, National Cancer Institute, Bethesda, Md. Infected cells treated with uninfected
mouse serum or plasma and fluoresceinated antibody to murine IgG did not stain.
Lymphoid Cell Preparations
Immediately after exsanguination, the animals' thymuses and spleens were removed and single
cell suspensions prepared by gently mincing with sharp scalpels. Tissue fragments andcell aggregates
were removed by sedimentation at 1 g for 30 min at 4°C and/or by passage through a nylon mesh.
Viability was determined by the trypan blue dye exclusion test.
To further purify lymphocytes, Ficoll-Hypaque gradient centrifugation was used (19). Macro-
phages were removed by suspending gradient purified cells in MEM with 5% heat-inactivated FCS,
through a nylon wool column (Fenwall Laboratories, Morton Grove, Ill.) . In a few experiments,
macrophages were removed by repeated passages on glass surfaces. A neutral red dye test (dyeLARS B . GILDING, FRED C . JENSEN, AND MICHAEL B . A . OLDSTONE
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concentration of 1/6,000) showed 0.5% or less macrophage contamination. Thymus-derived (T) cells
were purified by removing bone marrow-derived (B) cells with anylon wool column (20), or by usinga
rabbit antibody to B cells with a complement (C) source (21) . This antisera was kindly provided by
Dr . Robert Blanden, Department of Microbiology, The John Curtin School of Medical Research,
Canberra City, Australia . B-lymphoid cells were purified by killingT cells with anti-B serumand C.
The methodology for preparation and use of these various antisera and their specificities have been
reported (21, 22) . Briefly, anti-B sera inhibitedthe formation ofantibody by plaque-forming cells but
did not inhibit T-cell-dependent cytotoxicity, whereas anti-B sera did not abrogate the formation of
antibody by plaque-forming cells but did abolish T-cell killing in the assay of Brunner et al . (23) .
Further purity of each lymphoid population wasjudged by staining with FITC-conjugated antibody
to B-antigen . In none of the B-cell populations were cells with surface B-antigen seen .
Spleen cells were disrupted by treatment for 15 s x 4 with 1 min rests at 1.3-1.5A in aRaytheon
model DF101 Sonic oscillator (Raytheon Data Systems Co ., Norwood, Mass .) . Cell disruption was
confirmed microscopically .
Co-Cultivation Technique
Suspensions of either 1-5 x 10' lymphoid cells from whole spleens or purifiedBor T lymphocytes
from infected animals were mixed with 1-2 x 106MEC and planted in 60 x 15-mm plastic petri
dishes . The primary MEC were prepared from histoincompatible embryos . Controls consisted of
lymphocytes mixedwith 1-5 x 106 MEC from isologous donors . In some experiments, suspensions of
spleen or thymus cells from infected mice were cultured alone-since such cells provide their own layer
of fibroblasts . All cultures were run at least in triplicate and were nourished with growth media
initially and every week thereafter for 4-7 wk . Nonadhering lymphoid cells were kept in the cultures
by carefully collecting the supernatant fluid from the cultures, pelleting the cellsby centrifugation at
400g for 10 min, resuspending these cells in fresh growth media, and putting them back on the feeder
layer . Incubation was at 37°C in 5% CO, . Cultures were checked at least every other day for evidence
of CPE.
Mitogenic Stimulation
Suspensions of 5 x 10' lymphocytes from the spleens of 6- to 8-wk old C,H/St mice infected at
birth with MCMV and mixed with 5 x 10 6 isologous MEC were cultured with various mitogens:
lipopolysaccharide (LPS) (kindly provided by Dr. DavidC . Morrison, Scripps Clinic and Research
Foundation, La Jolla, Calif., and prepared as described elsewhere [24P, 10 leg/ml medium ; pokeweed
mitogen (PWM) (Grand Island Biological Co ., Grand Island, N . Y.), 50 Wg/ml medium ; concanavalin
A (Con A) (Miles-Yeda Ltd., Rehovet, Israel, crystallized three times), 1, 5, and 10 gg/ml medium ;
and phytohemagglutinin-P (PHA-P) (Difco Laboratories, Detroit, Mich .), 50 ug/ml . The dosages
selected for the various mitogens hadgiven maximal stimulation as determinedby earlier experiments
with murine lymphocytes . An enriched medium was employed as described (25) except that Earle's
balanced salt solution wasused and nucleic acid precursors omitted . All cultures were incubated with
5% CO, in air at 37°C . The ability ofvarious mitogens to initiate blast transformation wasobserved in
concurrent cultures containing 5 x 10' lymphocytes (in 2 ml of growth media) from spleens of mice
infected with MCMV. After3 days of culture, 1 .0 ACi of [methyl-'H ]thymidine (spe act6.7 Ci/mmol,
New England Nuclear Corp., Boston, Mass .) was added to each culture. 4 h later the cultures were
placed in an ice bath ; cells were washed three times in cold PBS, resuspended in bovine serum
albumin (1 mg/ml) and precipitated with 20% TCA . The precipitates were collected on Whatman
GF/A filters, dried, suspended in Aquasol (New England Nuclear Corp .) and counted in a Beckman
LS-230 liquid scintillation counter (Beckman Instrument, Inc ., Fullerton, Calif.) . 5 x 10' lympho-
cytes from infected and uninfected mice cultured without mitogens were handled in an identical
manner and served as controls .
Identification ofMCMV
Immunofluorescence . Cells from cultures with CPE were fixed and stained on cover slips as
described aboveby using a monospecific rabbit antibody toMCMV conjugated with FITC which had
been previously absorbed with normal MEC.564
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Neutralization Test .
￿
Supernate and cells from cultures showing CPE were collected, sonicated,
and layered in varying dilutions on monolayers prepared from BALB/c MEC in order to determine
the number of focus-forming units (FFU) present. A volume of media containing 25-50 FFU of the
virus was mixed with an equal volume of MEM containing serial twofold dilutions of monospecific
rabbit antibody (heated at 56°C for 30 min) to MCMV and incubated at 37°C for 30 min. The
mixture was absorbed on confluent monolayer cultures of BALB/c MEC for 60 min at 37 °C, then
removed, and the monolayer was overlaid with agar containing 2% FCS. Controls consisted of
cultures incubated with material showing CPE but not treated with antiserum, as well as cultures
incubated with antiserum alone. Quadruplicate cultures were used throughout. Cultures were again
overlaid with agar on the 5th day and examined for CPE on the 10th day when the serum dilution
showing a 50% reduction of CPE was determined.
Histologic andElectron Microscopic Studies.
￿
Cultured cells on cover slips were fixed in absolute
methanol and stained by May-Griinewald and Giemsa stains. For electron microscopy, pellets of
infected cells initially suspended in 0.025% trypsin and washed in FCS were fixed in 2.5%
glutaraldehyde and examined by Professor Peter Lampert, Department of Pathology, University of
California, Medical School, San Diego, Calif.
Results
Clinical State of Mice Infected with MCMV.
￿
Over 75% of mice delivered from
mothers infected during pregnancy survived, yet only 50% of C3H/St and
Ha/ICR mice and 10% of C3H/HeJ and nude mice infected at birth survived the
1st mo of life. Infectious virus was not found in the plasma from weanling or older
C3H/St, C3H/HeJ, or Ha/ICR mice . In contrast, antibodies to MCMV were
found in all the C3H/St and C3H/HeJ, and over 75% of Ha/ICR mice tested .
Recovery of MCMVfrom Lymphoid Cells of theSpleen.
￿
When suspensions of
spleen cells from C3H/HeJ or Ha/ICR mice were co-cultivated with isologous
MEC, no CPE appeared during 6-8 wk of culture. In contrast, when the spleen
cells were co-cultured with allogenic MEC, CPE usually appeared during the 2nd
to 3rd wk (Table I) . Sometimes, CPE spread rapidly; within 3-4 days the changes
had progressed from occasional megalic fibroblasts to involvement of virtually all
of the cells (Fig. 1 A-C) . On occasion, only one or two of the triplicate or
quadruplicate cultures became infected during the observation period. At times,
cultures had to be fed with fresh MEC to replace those fibroblasts destroyed by
the lymphoid cells before CPE began. When lymphoid cellswere sonicated before
being cultured with isologous MEC, no infectious virus was released.
Lymphocyte Subclass Harboring Latent MCMV. Co-cultures of purified
preparations of T-lymphoid cells from the thymus or the spleens of neonatally
infected 3-mo old mice with allogenic MEC yielded no CPE over a period of 7 wk
observation (Table II). In contrast, from the same lymphoid pools and under
similar conditions MCMV was easily recovered from B lymphoid cell populations
with CPE appearing by the 3rd wk. CPE did not occur when B-cell preparations
were co-cultured with isologous MEC.
To ensure that MCMV could grow in B lymphocytes, we studied the effects of
this virus in nude mice. Such mice have a congenital absence of thymus (T-less)
and represent a convenient animal model for dissecting T-cell, B-cell function .
Nude mice infected at birth with MCMV generally die within 3 wk of systemic
MCMV disease. We took spleen cells from such infected mice 2 wk after
instituting infection, and removed macrophages (passage on glass adhering
surface or nylon wool) and theta-bearing cell contamination by treatment withLARS B . OLDING, FRED C. JENSEN, AND MICHAEL B. A . OLDSTONE
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TABLE I
Recouery ofMCMVfrom Spleen Lymphoid Cells ofAdult Mice WhichHad Been Infected
In Utero or at Birth
* Virus identified as MCMV by immunofluorescence and neutralization test (see Materials and
Methods) .
$ 1-5 x 10' spleen cells co-cultured with 1-2 x 10 5 MEC in MEMcontaining 10% FCS. Cultures made
in triplicate or quadruplicate .
§Pregnant mice injected i.p . with 1,000 TCID 54 ofMCMV, or newborn mice injected i.p. with 100
TCID64 within 24 h of birth .
II Major histocompatibility complex (H-2) .
9 Number of cultures from whichMCMV wasrecovered over the total number of cultures observed .
Results are from one experiment . Three additional experiments gave similar results .
anti-B serum and C . When the remaining lymphoid cells were co-cultured with
BALB/c MEC, CPE occurred within 1 wk . This occurred with both intact cells
and cells disrupted by sonication (Table III) .
Activation of Virus by Mitogens .
￿
Lymphoid cells from the spleens of 6- to
8-wk old mice infected with MCMV at birth were mixed with various mitogens
and co-cultured with isologous MEC . Varying doses ofPWM, Con A, and PHA-P
did not activate virus during a 7-wk old observation period . The inability to
recover virus with these mitogens occurred despite active blastogenesis as
measured by the incorporation of free [ 3H ]thymidine into [ 3H ]thymidine TCA
precipitable counts in cultured cells . In contrast virus was obtained when these
infected lymphoid cells were cultured with LPS and isologous MEC . 10pg/ml of
LPS added to 5 x 106 lymphoid cells resulted in the largest amount of
[ 3H ]thymidine incorporation into TCA precipitable counts and to the recovery of
virus .
There was no significant difference in the incorporation of [ 9H]thymidine into
TCA precipitable cell counts among mitogen-stimulated lymphoid cells from
MCMV infected and uninfected mice . In a typical experiment, incubation of 5 x
106 lymphoid cells from infected mice with 10 ug LPS or 50pgPWM resulted in
an average of 11,492 and 9,159 TCA precipitable cpm, respectively . Incubation of
similar numbers oflymphoid cells from uninfected mice with these mitogens led
to 22,404 and 6,282 TCA precipitable cpm, respectively . Cells not stimulated
with mitogens gave the following counts : infected cells, 563 ; uninfected cells,
1,437 .
Identification of Recovered Virus .
￿
The virus in each culture showing CPE
Spleen cell donor
MCMV recovery* after
cells$
co-culture with
from :
embryo
No . of MCMV
C3H/HeJ BALB/c SWR/J
Strain mice injec- Age
(H-2kk) II (H-2°d) II (H-244) II
Ha/ICR
(pool) tion§
mo
C3H/HeJ 3 In utero 2 0/4~f 4/4 4/4 ND
C3H/HeJ 3 At birth 2 0/4 4/4 3/4 ND
Ha/ICR 3 In utero 5 ND 3/4 2/4 0/4X
r
C O V
d
W
d h 7
V .d
f .
3
0
N
d
0
U
C O
.m
W
V
Q
d
U
k
N
b
d
R
m
b
O
~pN
dW
V~ .F
O
O
3
0 W N
U_ W U
.~ O W
7 .a y 'b t"
A
H
`°
.~
Q3
o
to
mm w a~ W
y .c w
a!
a
N
o ~U
O
O r.
T 3.=
~. "b T
O
CV
C
..OW
A 0 N
U
O
O^
G
cU
U O7 y d
O >'
O
0 .
w 13LARS B. OLDING, FRED C . JENSEN, AND MICHAEL B . A. OLDSTONE
￿
567
TABLE II
Recovery ofMCMV From Purified Populations ofB Lymphocytes of Adult Mice Which
Had Been Infected at Birth*
Noof .
MCMV recovery
after co-culture
* Newborn mice injected i.p . with 100 TCIDsu of MCMV within 24 h of birth .
$Lymphocytes purified by Ficoll-Hypaque gradient centrifugation . Macrophagesand Blymphocytes
removed by passage through a nylon wool column . T lymphocytes killed by treatment with a
congenic anti-B antiserum andguinea pig C(see MaterialsandMethods) .
§Number of cultures from which MCMV was recovered over total number of cultures observed .
Results are from one experiment . Additional experiments gave similar results .
TABLE III
Recovery ofMCMV from B Lymphocytes of Infected Nude Mice*
* Homozygous nude (n/n) mice from BALB/c background injected i .p. with 200TCID bo ofMCMV .
$ Lymphocytes were obtained by Ficoll-Hypaque gradient centrifugation . Purified lymphocytes
deprived of macrophageswere treatedwith acongenic anti-B antiserumand guinea pigC.
§Number of cultures from which MCMV was recovered over total number of cultures observed .
was positively identified as MCMV by the occurrence of characteristic intranu-
clear viral inclusions when stained by fluoresceinated specific antibody to
MCMV (Fig . 2) . Further, virus recovered from lymphocytes was specifically
neutralized by antibodies toMCMV . In addition, electron microscopy of infected
cells showed viral structures typical for the herpes virus group (Fig . 2), and light
microscopy showed the characteristic nuclear inclusions usually associated with
CMV (Fig . 2) .
Discussion
Throughout life, virus remains in a latent state in the lymphocytes of many mice
infected in utero or at birth with MCMV . Although this virus cannot be detected
Strain mice
(pool)
Age
mo
Tissue source
Lymphocyte
preparation$
with histoin-
compatible
embryo cells
(BALB/c)
C3H/St 4 3 Thymus T 0/3§
C3H/St 4 3 Spleen T 0/3
C3H/St 4 3 Spleen B 2/3
C3H/St 4 3 Spleen B+T 2/3
No . of mice
(pool)
Days after
infection
Tissue source
Lymphocyte
preparation$
MCMV recovery
after co-culture
with embryo
cells
3 17 Spleen Crude 2/3 §
3 17 Spleen B cells, alive 3/3
3 17 Spleen B cells, sonicated 3/3FIG. 2 .
￿
Identification ofMCMV as the agent activated from lymphocytes of adultmice after
co-culture with allogenicMEC: (A) characteristic nuclear inclusions are seen in cells stained
with May-Griinewald and Giemsa, x 900 ; (B) recovered virus identified as MCMV by
immunofluorescence using a rabbit antibody to MCMV conjugated with FITC . Intranuclear
viral inclusions specifically stained (arrows), x 1,000 ; and (C) ultrastructure of recovered virus
showing icosahedral nucleocapsids typical for herpes viruses (glutaraldehyde fixation, x 50,000) .
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Us ofT-less homologous
both glass adherent and contaminating theta-beari
. Purified T cells show no such virus, Thus CMV, which had
ly capable ofbecoming activated to replicate in B cell-, and
could be recovered from them . Recently, both cultured human B-cell lines and
peripheral B but not T cells have been reported to have receptors for
Epstein-Bart virus, which like CMV is in the herpes virus group (26) .
We are aware that techniques used to obtain subpopulations of lymphocytes
have their limitations .
For example, glass surfaces or nylon fibers may remove
some lymphoblasts as well as macrophages ; cells otherthanB orT cellscom
lymphoid populat
may vary
fibroblasts . No
being cultured or
like conditions with
blast transforma
one, a B-lymphocyte mitogen, LPS, was adequate to activate MCMV . We
conclude that (a) virus can be present in lymphocytes in a noninfectious form ;
(b) cell division is needed for virus activation ; (C) allogenic stimulation leads to
virus activation ; and (d) the B-cell mitogen, LPS, activates virus . Factors other
than those we tried may also be important in activating this virus.
Others have shown that marine leukemia virus (MuLV) can be activated both
by means of a graft vs . host reaction and in vitro by
lymphocyte cultures containing various anti-H-2 cells (27-30) . In contrast to our
study, the mitogens they used were unable to activate MuLVfrom lymphocytes.
Similar to our findings, co-cultivation with allogenic cells did release virus . In
contrast to MCMV, MuLV is apparently released from T and not from B
lymphocytes .
We found no evidence that persistence of MCMV was associated with any
dysfunction of lymphocyte responses to various mitogens . Thus lymphoid cells
from the spleens of adult mice which had been infected at birth with MCMV
population received any contributi
e first detected in marine lymphocyte cultures at di
more often during the 3rd
eleased more
erologous B- and T-cell populations . Occasion-
ally, only one or two of four cultures became positive . These results suggest that
all lymphocytesmay not harbor thevirus, and that thosehaving virus carry very
little . In preliminary experiments in which ['H]thymidine-labeled MCMVDNA
washybridized to lymphocytes, therewasan average of less than one copy ofviral
DNA per B lymphocyte (Kingsbury, Olding, and Oldstone, unpublished data).
MCMV was recovered from lymphocytes after co-cultivation with allogenic
detected when these lymphocyteswere disrupted before
lymphocytes, iota
sologous fibroblasts or those with similar H-2 loci .
occurred after addition of several mitogens . However, only570
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responded with similar mitogenic indices as did uninfected age and sex matched
controls to LPS, PWM, Con A, and PHA-P .
In several human diseases, CMV becomes activated (1, 2) by mechanisms that
are not understood . Based on our observations that MCMV is activated from
lymphocytes after allogenic stimulation in vitro, and on the known association of
CMV activation and allogenic immunologic reaction in vivo (after human renal
transplants, blood transfusions, and pregnancies), it seems likely that latent
CMV can be activated from lymphocytes of the recipient or perhaps the donor
during allogenic stimulation as previously intimated (32) . Experiments to test
this hypothesis in man and to activate MCMV in vivo are presently under way .
Similar pathogenic mechanisms may, in part, explain the occurrence of infec-
tious mononucleosis particularly in the post-transfusion syndrome . Our observa-
tions add additional evidence that viruses are carried in lymphocytes (reviewed
in reference 31) . If a parallel exists in other infectious diseases or in those chronic
disorders believed to be associated with viral infection, then the techniques de-
scribed here may be applicable to recovering viruses from those patients .
Finally, in addition to demonstrating that latentMCMV is carried and can be
activated in B lymphocytes, our experiments with nude mice clearly showed that
virus replicated in theirB lymphocytes . Similar observations were made in other
murine strains and rarely in a C3H/St mouse. In all these instances, virus was
recovered rapidly and directly from lymphocytes without allogenic co-cultiva-
tion . Others have successfully recovered CMV from lymphoid tissues and
peripheral blood cells (33-36) .
Summary
After infection in utero or at birth with a cell culture adapted strain of mouse
cytomegalovirus (MCMV), several mouse strains developed a latent virus
infection in the presence of specific antiviral antibodies . Up to 5 mo after
infection, MCMV could be activated and recovered from spleen lymphocytes of
the infected animals that were co-cultivated with histoincompatible (H-2
foreign) mouse embryo cells from uninfected animals . In contrast, co-cultivation
of lymphoid cells from infected mice with mouse embryo cells from syngeneic,
histocompatible (H-2 similar) donors did not activate MCMV . Similarly,
MCMV was not recovered from sonicated lymphoid cells . Virus was activated by
treating viable lymphoid cells with lipopolysaccharide, a B-cell mitogen, but was
not activated by a variety of other mitogens such as phytohemagglutinin,
concanavalin A, or pokeweed mitogen. Subsequent purification of lymphoid cells
from infected mice by a variety of techniques indicated that MCMV was
harbored in the R-lymphocyte population .
We thank Professor Peter W . Lampert, University of California at San Diego, School of Medicine, and
Dr . David Kingsbury, University of California at Irvine, School of Medicine, for their help in part of
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